CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: quinone imine
Accession: CHEBI:50193
browse the term
Definition: An imine formed formally from a quinone by replacement of one or more atoms of quinonoid oxygen by =NH or =NR.
Synonyms: related_synonym: quinone imines; quinoneimine; quinoneimines
G
Bcl2l1
Bcl2-like 1
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in decreased expression of BCL2L1 mRNA
CTD
PMID:21034357
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Ccl4
C-C motif chemokine ligand 4
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CCL4 mRNA
CTD
PMID:21034357
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CDKN1A mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CDKN1A protein
CTD
PMID:21034357
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cntf
ciliary neurotrophic factor
multiple interactions
ISO
2,6-Dichloroindophenol inhibits the reaction [Cadmium Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT1 protein]]; 2,6-Dichloroindophenol inhibits the reaction [Cadmium Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT3 protein]]
CTD
PMID:19635391
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
G
Cryab
crystallin, alpha B
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CRYAB mRNA
CTD
PMID:21034357
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CXCL10 mRNA
CTD
PMID:21034357
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Egr1
early growth response 1
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of EGR1 mRNA
CTD
PMID:21034357
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Ephx2
epoxide hydrolase 2
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of EPHX2 mRNA
CTD
PMID:21034357
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Faslg
Fas ligand
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of FASLG mRNA
CTD
PMID:21034357
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GADD45A mRNA
CTD
PMID:21034357
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gdf15
growth differentiation factor 15
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GDF15 mRNA
CTD
PMID:21034357
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gstm5
glutathione S-transferase, mu 5
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GSTM3 mRNA
CTD
PMID:21034357
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HMOX1 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HMOX1 protein
CTD
PMID:21034357
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA1A mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA1A protein
CTD
PMID:21034357
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa2
heat shock protein family A (Hsp70) member 2
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA2 mRNA
CTD
PMID:21034357
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA6 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA6 protein
CTD
PMID:21034357
NCBI chr13:83,273,176...83,274,317
G
Lta
lymphotoxin alpha
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of LTA mRNA
CTD
PMID:21034357
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of NOS2 mRNA
CTD
PMID:21034357
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions increases reduction increases response to substance
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in decreased expression of BCL2L1 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CCL4 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CDKN1A mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CDKN1A protein; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CRYAB mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CXCL10 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of EGR1 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of EPHX2 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of FASLG mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GADD45A mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GDF15 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of GSTM3 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HMOX1 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HMOX1 protein; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA1A mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA1A protein; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA2 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA6 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of HSPA6 protein; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of LTA mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of NOS2 mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of TNF mRNA; [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased phosphorylation of TP53 protein; Carbamazepine inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol]; Diclofenac inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol]; Dicumarol inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol]; Mefenamic Acid inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol]; NQO1 protein inhibits the reaction [2,6-Dichloroindophenol results in decreased abundance of Glutathione]; NQO1 protein polymorphism promotes the reaction [2,6-Dichloroindophenol results in decreased abundance of Glutathione]; Tacrine inhibits the reaction [NQO1 protein results in increased reduction of 2,6-Dichloroindophenol] NQO1 protein polymorphism results in increased susceptibility to 2,6-Dichloroindophenol
CTD
PMID:21034357 PMID:29281794
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
multiple interactions increases reduction
ISO
[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of 2,6-Dichloroindophenol; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of 2,6-Dichloroindophenol; resveratrol inhibits the reaction [NQO2 protein results in increased reduction of 2,6-Dichloroindophenol]; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of 2,6-Dichloroindophenol]
CTD
PMID:20399199 PMID:29281794
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
2,6-Dichloroindophenol inhibits the reaction [Cadmium Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT1 protein]]
CTD
PMID:19635391
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
2,6-Dichloroindophenol inhibits the reaction [Cadmium Chloride inhibits the reaction [CNTF results in increased phosphorylation of STAT3 protein]]
CTD
PMID:19635391
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of TNF mRNA
CTD
PMID:21034357
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions
ISO
[2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased phosphorylation of TP53 protein
CTD
PMID:21034357
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
ISO
Bandrowski's base results in increased expression of AKR1B1 mRNA
CTD
PMID:20566472
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Bandrowski's base results in increased expression of AKR1B10 mRNA
CTD
PMID:20566472
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
Bandrowski's base results in increased expression of AKR1C1 mRNA
CTD
PMID:20566472
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
Bandrowski's base results in increased expression of AKR1C3 mRNA
CTD
PMID:20566472
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Cat
catalase
increases expression
ISO
Bandrowski's base results in increased expression of CAT mRNA
CTD
PMID:20566472
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl17
C-C motif chemokine ligand 17
affects expression
ISO
Bandrowski's base affects the expression of CCL17 mRNA
CTD
PMID:18202158
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl22
C-C motif chemokine ligand 22
affects expression
ISO
Bandrowski's base affects the expression of CCL22 mRNA
CTD
PMID:18202158
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl4
C-C motif chemokine ligand 4
affects expression
ISO
Bandrowski's base affects the expression of CCL4 mRNA
CTD
PMID:18202158
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccr7
C-C motif chemokine receptor 7
affects expression increases expression
ISO
Bandrowski's base affects the expression of CCR7 mRNA Bandrowski's base results in increased expression of CCR7 protein
CTD
PMID:18202158 PMID:19665512
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Cd80
Cd80 molecule
increases expression
ISO
Bandrowski's base results in increased expression of CD80 protein
CTD
PMID:31958493
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd86
CD86 molecule
affects expression multiple interactions increases expression
ISO
Bandrowski's base affects the expression of CD86 mRNA MIR146A affects the reaction [Bandrowski's base results in increased expression of CD86 protein]; PRKCB protein affects the reaction [Bandrowski's base results in increased expression of CD86 protein]
CTD
PMID:18202158 PMID:19665512 PMID:21742781 PMID:31958493 PMID:37326882
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cxcr4
C-X-C motif chemokine receptor 4
affects expression
ISO
Bandrowski's base affects the expression of CXCR4 mRNA
CTD
PMID:18202158
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Fech
ferrochelatase
increases expression
ISO
Bandrowski's base results in increased expression of FECH mRNA
CTD
PMID:20566472
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
G
Ftl1
ferritin light chain 1
increases expression
ISO
Bandrowski's base results in increased expression of FTL mRNA
CTD
PMID:20566472
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
Bandrowski's base results in increased expression of G6PD mRNA
CTD
PMID:20566472
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
Bandrowski's base results in increased expression of GCLC mRNA
CTD
PMID:20566472
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Bandrowski's base results in increased expression of GCLM mRNA
CTD
PMID:20566472
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
Bandrowski's base results in increased expression of GPX3 mRNA
CTD
PMID:20566472
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
Bandrowski's base results in increased expression of GSR mRNA
CTD
PMID:20566472
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
increases expression
ISO
Bandrowski's base results in increased expression of HMOX1 mRNA
CTD
PMID:20566472
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Icam1
intercellular adhesion molecule 1
increases expression affects expression
ISO
Bandrowski's base results in increased expression of ICAM1 protein Bandrowski's base affects the expression of ICAM1 mRNA
CTD
PMID:18202158 PMID:21742781
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
Bandrowski's base results in increased expression of MAFF mRNA
CTD
PMID:20566472
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression
ISO
Bandrowski's base results in increased expression of MAFG mRNA
CTD
PMID:20566472
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
G
Mafk
MAF bZIP transcription factor K
increases expression
ISO
Bandrowski's base results in increased expression of MAFK mRNA
CTD
PMID:20566472
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Me1
malic enzyme 1
increases expression
ISO
Bandrowski's base results in increased expression of ME1 mRNA
CTD
PMID:20566472
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
ISO
Bandrowski's base results in increased expression of MGST1 mRNA
CTD
PMID:20566472
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
G
Mir146a
microRNA 146a
multiple interactions
ISO
MIR146A affects the reaction [Bandrowski's base results in increased expression of CD86 protein]
CTD
PMID:37326882
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir155
microRNA 155
increases expression
ISO
Bandrowski's base results in increased expression of MIR155 mRNA
CTD
PMID:32939143
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir21
microRNA 21
decreases expression
ISO
Bandrowski's base results in decreased expression of MIR21 mRNA
CTD
PMID:32939143
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Bandrowski's base results in increased expression of NQO1 mRNA
CTD
PMID:20566472
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
Bandrowski's base results in increased expression of PGD mRNA
CTD
PMID:20566472
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Ppia
peptidylprolyl isomerase A
affects expression
ISO
Bandrowski's base affects the expression of PPIA mRNA
CTD
PMID:18202158
NCBI chr14:81,279,292...81,282,960
Ensembl chr14:81,275,091...81,299,601
G
Prkcb
protein kinase C, beta
increases expression multiple interactions
ISO
Bandrowski's base results in increased expression of PRKCB protein PRKCB protein affects the reaction [Bandrowski's base results in increased expression of CD86 protein]
CTD
PMID:31958493 PMID:37326882
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
Bandrowski's base results in increased expression of PTGR1 mRNA
CTD
PMID:20566472
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Sod1
superoxide dismutase 1
increases expression
ISO
Bandrowski's base results in increased expression of SOD1 mRNA
CTD
PMID:20566472
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases expression
ISO
Bandrowski's base results in increased expression of SOD2 mRNA
CTD
PMID:20566472
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
increases expression
ISO
Bandrowski's base results in increased expression of SOD3 mRNA
CTD
PMID:20566472
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Bandrowski's base results in increased expression of SRXN1 mRNA
CTD
PMID:20566472
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Tnfrsf1a
TNF receptor superfamily member 1A
affects expression
ISO
Bandrowski's base affects the expression of TNFRSF1A mRNA
CTD
PMID:18202158
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Txn2
thioredoxin 2
increases expression
ISO
Bandrowski's base results in increased expression of TXN2 mRNA
CTD
PMID:20566472
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Bandrowski's base results in increased expression of TXNRD1 mRNA
CTD
PMID:20566472
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
Bandrowski's base results in increased expression of TXNRD2 mRNA
CTD
PMID:20566472
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
increases expression
ISO
Bandrowski's base results in increased expression of UGT1A6 mRNA
CTD
PMID:20566472
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Acta2
actin alpha 2, smooth muscle
increases expression multiple interactions
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA; N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 mRNA]; andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of ACTA2 protein]
CTD
PMID:28286204 PMID:29355602
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adarb2
adenosine deaminase RNA specific B2
affects response to substance
ISO
ADARB2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr17:61,750,437...62,300,984
Ensembl chr17:61,756,067...62,300,831
G
Alcam
activated leukocyte cell adhesion molecule
affects response to substance
ISO
ALCAM gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
affects response to substance
ISO
ALDH1A3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
G
Bmp2
bone morphogenetic protein 2
increases expression
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of BMP2 mRNA
CTD
PMID:28286204
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Bpnt2
3'(2'), 5'-bisphosphate nucleotidase 2
affects response to substance
ISO
BPNT2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 5:17,775,684...17,802,570
Ensembl chr 5:17,772,608...17,802,570
G
C11h3orf38
similar to human chromosome 3 open reading frame 38
affects response to substance
ISO
C3ORF38 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr11:2,483,983...2,488,631
Ensembl chr11:2,481,189...2,488,660
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
affects response to substance
ISO
CACNA1H gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cald1
caldesmon 1
affects response to substance
ISO
CALD1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Ccdc25
coiled-coil domain containing 25
affects response to substance
ISO
CCDC25 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr15:40,055,368...40,087,758
Ensembl chr15:40,055,368...40,087,758
G
Cd9
CD9 molecule
affects response to substance
ISO
CD9 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cep44
centrosomal protein 44
affects response to substance
ISO
CEP44 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr16:33,711,548...33,733,226
Ensembl chr16:33,711,559...33,733,225
G
Cnr1
cannabinoid receptor 1
affects response to substance
ISO
CNR1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
Col1a1
collagen type I alpha 1 chain
increases expression multiple interactions
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of COL1A1 mRNA andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL1A1 mRNA]
CTD
PMID:28286204 PMID:29355602
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
increases expression
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of COL1A2 mRNA
CTD
PMID:28286204
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
increases expression multiple interactions
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of COL3A1 mRNA andrographolide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of COL3A1 mRNA]
CTD
PMID:28286204 PMID:29355602
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Cpa6
carboxypeptidase A6
affects response to substance
ISO
CPA6 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 5:8,526,708...8,888,492
Ensembl chr 5:8,526,741...8,888,485
G
Cst5
cystatin D
affects response to substance
ISO
CST5 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 3:137,573,194...137,577,754
Ensembl chr 3:137,573,194...137,577,754
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases abundance
ISO
CYP1A2 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine CYP1A2 protein results in increased abundance of N-acetyl-4-benzoquinoneimine
CTD
PMID:19679878 PMID:24661219
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases abundance
ISO
CYP2D6 protein results in increased abundance of N-acetyl-4-benzoquinoneimine
CTD
PMID:24661219
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions increases abundance increases chemical synthesis
ISO EXP
CYP2E1 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine CYP2E1 protein results in increased abundance of N-acetyl-4-benzoquinoneimine CYP2E1 results in increased chemical synthesis of N-acetyl-4-benzoquinoneimine
CTD
PMID:19679878 PMID:20566340 PMID:24661219
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases abundance
ISO
CYP3A4 protein results in increased abundance of N-acetyl-4-benzoquinoneimine
CTD
PMID:24661219
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Dmrt1
doublesex and mab-3 related transcription factor 1
affects response to substance
ISO
DMRT1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
G
Dnttip1
deoxynucleotidyltransferase, terminal, interacting protein 1
affects response to substance
ISO
DNTTIP1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 3:153,481,718...153,505,403
Ensembl chr 3:153,481,705...153,505,759
G
Dsc3
desmocollin 3
affects response to substance
ISO
DSC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
G
Etnk2
ethanolamine kinase 2
affects response to substance
ISO
ETNK2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr13:44,811,012...44,829,052
Ensembl chr13:44,811,015...44,829,037
G
Fbxo39
F-box protein 39
affects response to substance
ISO
FBXO39 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906
G
Frk
fyn-related Src family tyrosine kinase
affects response to substance
ISO
FRK gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114
G
Gpx1
glutathione peroxidase 1
multiple interactions affects response to substance
ISO
[GPX1 protein co-treated with SOD1 protein] affects the susceptibility to N-acetyl-4-benzoquinoneimine GPX1 protein affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:16636302
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gstp1
glutathione S-transferase pi 1
affects metabolic processing multiple interactions increases glutathionylation increases metabolic processing
ISO EXP
GSTP1 protein polymorphism affects the metabolism of N-acetyl-4-benzoquinoneimine metabolite NQO1 protein inhibits the reaction [GSTP1 protein results in increased glutathionylation of N-acetyl-4-benzoquinoneimine] GSTP1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine
CTD
PMID:24185126 PMID:24552538
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hdac4
histone deacetylase 4
affects response to substance
ISO
HDAC4 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hid1
HID1 domain containing
affects response to substance
ISO
HID1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr10:100,589,555...100,610,050
Ensembl chr10:100,589,555...100,610,041
G
Il23r
interleukin 23 receptor
affects response to substance
ISO
IL23R gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
affects response to substance
ISO
KCNJ3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 3:39,944,896...40,106,646
Ensembl chr 3:39,945,351...40,109,124
G
Kcnu1
potassium calcium-activated channel subfamily U member 1
affects response to substance
ISO
KCNU1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr16:66,141,696...66,229,493
Ensembl chr16:66,141,976...66,229,465
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions affects metabolic processing
ISO
KEAP1 protein inhibits the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] N-acetyl-4-benzoquinoneimine affects the metabolism of KEAP1 protein
CTD
PMID:18785192 PMID:19246624
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Lama4
laminin subunit alpha 4
affects response to substance
ISO
LAMA4 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
G
Lmx1a
LIM homeobox transcription factor 1 alpha
affects response to substance
ISO
LMX1A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr13:79,834,614...79,978,253
Ensembl chr13:79,835,019...79,978,253
G
Magi2
membrane associated guanylate kinase, WW and PDZ domain containing 2
affects response to substance
ISO
MAGI2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
N-acetyl-4-benzoquinoneimine results in increased phosphorylation of MAPK1 protein
CTD
PMID:28286204
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
N-acetyl-4-benzoquinoneimine results in increased phosphorylation of MAPK3 protein
CTD
PMID:28286204
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mctp1
multiple C2 and transmembrane domain containing 1
affects response to substance
ISO
MCTP1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833
G
Mfsd4a
major facilitator superfamily domain containing 4A
affects response to substance
ISO
MFSD4A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr13:43,469,488...43,510,467
Ensembl chr13:43,469,488...43,510,467
G
Mir135a
microRNA 135a
affects response to substance
ISO
MIR135A2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 7:26,611,990...26,612,089
Ensembl chr 7:26,611,990...26,612,089
G
Mmp2
matrix metallopeptidase 2
increases expression
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of MMP2 mRNA
CTD
PMID:28286204
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mtus2
microtubule associated scaffold protein 2
affects response to substance
ISO
MTUS2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr12:6,706,531...7,078,331
Ensembl chr12:6,706,532...7,078,331
G
Neb
nebulin
affects response to substance
ISO
NEB gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization multiple interactions increases activity
ISO
N-acetyl-4-benzoquinoneimine affects the localization of NFE2L2 protein NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] N-acetyl-4-benzoquinoneimine results in increased activity of NFE2L2 protein
CTD
PMID:18785192 PMID:19246624
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nhlrc3
NHL repeat containing 3
affects response to substance
ISO
NHLRC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 2:137,527,843...137,542,258
Ensembl chr 2:137,530,012...137,534,879 Ensembl chr 2:137,530,012...137,534,879
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions increases reduction increases metabolic processing increases expression
ISO
KEAP1 protein inhibits the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine]; NFE2L2 protein affects the reaction [N-acetyl-4-benzoquinoneimine results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [NQO1 protein results in increased metabolism of N-acetyl-4-benzoquinoneimine] NQO1 protein inhibits the reaction [GSTP1 protein results in increased glutathionylation of N-acetyl-4-benzoquinoneimine] NQO1 protein results in increased reduction of N-acetyl-4-benzoquinoneimine
CTD
PMID:17188792 PMID:18785192 PMID:19246624 PMID:24552538
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
multiple interactions
ISO
NQO2 protein results in increased reduction of and results in decreased glutathionylation of N-acetyl-4-benzoquinoneimine; Tacrine inhibits the reaction [NQO2 protein results in increased reduction of N-acetyl-4-benzoquinoneimine]
CTD
PMID:29281794
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Pcbd2
pterin-4 alpha-carbinolamine dehydratase 2
affects response to substance
ISO
PCBD2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr17:8,845,161...8,896,343
Ensembl chr17:8,845,084...8,910,539
G
Pvt1
Pvt1 oncogene
affects response to substance
ISO
PVT1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 7:93,656,528...93,879,938
G
Rab3il1
RAB3A interacting protein-like 1
affects response to substance
ISO
RAB3IL1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 1:206,646,168...206,682,718
Ensembl chr 1:206,646,155...206,679,972
G
Rap1gap2
RAP1 GTPase activating protein 2
affects response to substance
ISO
RAP1GAP2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr10:59,255,400...59,472,536
Ensembl chr10:59,255,278...59,472,170
G
Slc39a11
solute carrier family 39, member 11
affects response to substance
ISO
SLC39A11 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr10:98,275,958...98,697,042
Ensembl chr10:98,275,960...98,611,295
G
Slit2
slit guidance ligand 2
affects response to substance
ISO
SLIT2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
G
Snx16
sorting nexin 16
affects response to substance
ISO
SNX16 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 2:91,335,896...91,357,622
Ensembl chr 2:91,336,092...91,357,619
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
[GPX1 protein co-treated with SOD1 protein] affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:16636302
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Spag16
sperm associated antigen 16
affects response to substance
ISO
SPAG16 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 9:71,333,005...72,252,772
Ensembl chr 9:71,332,992...72,252,708
G
Stab1
stabilin 1
affects response to substance
ISO
STAB1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr16:6,330,435...6,360,934
Ensembl chr16:6,330,444...6,360,923
G
Syne3
spectrin repeat containing, nuclear envelope family member 3
affects response to substance
ISO
SYNE3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 6:123,872,895...123,964,773
Ensembl chr 6:123,873,174...123,953,409
G
Tac1
tachykinin, precursor 1
increases secretion
EXP
N-acetyl-4-benzoquinoneimine results in increased secretion of TAC1 protein
CTD
PMID:20720158
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of TGFB1 mRNA
CTD
PMID:28286204
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
N-acetyl-4-benzoquinoneimine results in increased expression of TIMP1 mRNA
CTD
PMID:28286204
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Top2a
DNA topoisomerase II alpha
decreases activity
ISO
N-acetyl-4-benzoquinoneimine results in decreased activity of TOP2A protein
CTD
PMID:15035644
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tpd52l1
TPD52 like 1
affects response to substance
ISO
TPD52L1 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases activity affects response to substance multiple interactions
ISO EXP
N-acetyl-4-benzoquinoneimine results in increased activity of TRPA1 protein TRPA1 affects the susceptibility to N-acetyl-4-benzoquinoneimine 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [N-acetyl-4-benzoquinoneimine results in increased activity of TRPA1 protein]
CTD
PMID:20720158
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Txnrd1
thioredoxin reductase 1
decreases activity multiple interactions
EXP
N-acetyl-4-benzoquinoneimine results in decreased activity of TXNRD1 protein Glutathione inhibits the reaction [N-acetyl-4-benzoquinoneimine results in decreased activity of TXNRD1 protein]
CTD
PMID:24661219
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ubash3a
ubiquitin associated and SH3 domain containing, A
affects response to substance
ISO
UBASH3A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr20:9,291,471...9,334,685
Ensembl chr20:9,292,139...9,329,224
G
Ube2e2
ubiquitin-conjugating enzyme E2E 2
affects response to substance
ISO
UBE2E2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr15:6,980,241...7,257,912
Ensembl chr15:6,980,474...7,257,532
G
Vwc2
von Willebrand factor C domain containing 2
affects response to substance
ISO
VWC2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr14:85,683,670...85,825,068
Ensembl chr14:85,684,414...85,818,524
G
Wfdc3
WAP four-disulfide core domain 3
affects response to substance
ISO
WFDC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine
CTD
PMID:21177773
NCBI chr 3:153,464,862...153,478,952
Ensembl chr 3:153,464,862...153,478,952
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19874
chemical entity
19872
atom
19872
nonmetal atom
19794
carbon atom
19748
organic molecular entity
19748
imine
194
quinone imine
133
1,4-benzoquinone imine +
73
2,6-dichloroindophenol
24
4'-hydroxydiclofenac quinone imine
0
5-hydroxydiclofenac quinone imine
0
6-iminocyclohexa-2,4-dienone
0
Bandrowski's base
43
LSM-32594
0
N-3,5-dichloro-4-hydroxyphenyl-1,4-benzoquinone imine
0
N-acetyl-1,4-benzoquinone imine
73
NG-061
0
Sarubicin A
0
Sorbicillamine D
0
Vegfrecine
0
indophenol +
24
para-Benzoquinone dioxime
0
Path 2
CHEBI ontology
19874
subatomic particle
19872
composite particle
19872
hadron
19872
baryon
19872
nucleon
19872
atomic nucleus
19872
atom
19872
main group element atom
19811
p-block element atom
19811
p-block molecular entity
19811
carbon group molecular entity
19751
organic molecular entity
19748
heteroorganic entity
19505
organonitrogen compound
18827
imine
194
quinone imine
133
1,4-benzoquinone imine +
73
2,6-dichloroindophenol
24
4'-hydroxydiclofenac quinone imine
0
5-hydroxydiclofenac quinone imine
0
6-iminocyclohexa-2,4-dienone
0
Bandrowski's base
43
LSM-32594
0
N-3,5-dichloro-4-hydroxyphenyl-1,4-benzoquinone imine
0
N-acetyl-1,4-benzoquinone imine
73
NG-061
0
Sarubicin A
0
Sorbicillamine D
0
Vegfrecine
0
indophenol +
24
para-Benzoquinone dioxime
0